The resources below will help you learn more about CML, including its diagnosis and its treatment with Glivec (imatinib).

Some resources are in PDF format. You need Adobe ® Reader ®, available free from Adobe, to download, view, and print PDF files.

CML Monograph (PDF), a clinical monograph of the disease

Effect of Therapy on CML (PDF), a paper about measuring the effect of therapy on CML

CML patient brochure (PDF), a brochure about the human impact of Glivec on CML

CML Molecular Target animation, a short animation on CML
The animation can be viewed with Apple Quicktime. At 56kbps, download time is estimated at about 25 minutes.

Second-Generation Tyrosine Kinase Inhibitors in the Treatment of Patients With Imatinib-Resistant Mutations

Francis J. Giles, MD
Cancer Therapy and Research Center
University of Texas Health Science Center
San Antonio, Texas

Safety and Efficacy of Second-Generation Tyrosine Kinase Inhibitors in Imatinib-Resistant and Intolerant CML

Michele Baccarani, MD
S.Orsola-Malpighi Hospital
University of Bologna
Bologna, Italy

Imatinib in Chronic Phase CML: Safe, Effective After 5 Years

Hagop Kantarjian, MD
M.D.Anderson Cancer Center
University of Texas
Houston, Texas

Imatinib Dose Escalation Shows Enhanced Efficacy in Chronic Phase CML

Timothy Hughes, MD, MBBS
Institute of Medical and Veterinary Science
University of Adelaide
Adelaide, Australia